<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6800501\results\search\disease\results.xml">
  <result pre="Science1021-77701423-0127BioMed CentralLondon pmcid: 6800501572 doi: 10.1186/s12929-019-0572-3 : Review M2e-based universal" exact="influenza" post="vaccines: a historical overview and new approaches to development"/>
  <result pre="made available in this article, unless otherwise stated. Abstract The" exact="influenza" post="A virus was isolated for the first time in"/>
  <result pre="virus began soon afterwards. In addition to causing seasonal epidemics," exact="influenza" post="viruses can cause pandemics at random intervals, which are"/>
  <result pre="is the most effective way of preventing the spread of" exact="influenza" post="infection. However, seasonal vaccination is ineffective against pandemic influenza"/>
  <result pre="of influenza infection. However, seasonal vaccination is ineffective against pandemic" exact="influenza" post="viruses because of antigenic differences, and it takes approximately"/>
  <result pre="action. The extracellular domain of the M2 protein (M2e) of" exact="influenza" post="A virus is a conservative region, and an attractive"/>
  <result pre="a conservative region, and an attractive target for a universal" exact="influenza" post="vaccine. This review gives a historical overview of the"/>
  <result pre="summarizes the latest developments in the preparation of M2e-based universal" exact="influenza" post="vaccines. Keywords Influenza a virus Influenza M2 ectodomain Conserved"/>
  <result pre="Influenza a virus Influenza M2 ectodomain Conserved protein Cross-protection Universal" exact="influenza" post="vaccine Funding http://dx.doi.org/10.13039/501100006769Russian Science Foundation 19-15-00015RudenkoLarisa Introduction The extremely"/>
  <result pre="Introduction The extremely high variability in the antigenic properties of" exact="influenza" post="virus is related to the structure of its genome"/>
  <result pre="drift variants. In addition, completely new antigenic variants of the" exact="influenza" post="virus are occasionally introduced into the human population; since"/>
  <result pre="viruses spread easily and can cause pandemics. These features of" exact="influenza" post="infection explain why there is interest around the world"/>
  <result pre="there is interest around the world in developing a universal" exact="influenza" post="vaccine, which could induce a cross-reactive immune response to"/>
  <result pre="to the most conservative parts of the viral proteins. Classic" exact="influenza" post="vaccines commonly induce antibodies to the viral surface antigens,"/>
  <result pre="need for annual updating of vaccine strains in the seasonal" exact="influenza" post="vaccines [95, 129]. The performance of seasonal influenza vaccines"/>
  <result pre="the seasonal influenza vaccines [95, 129]. The performance of seasonal" exact="influenza" post="vaccines can be improved by increasing the speed of"/>
  <result pre="will not be able to protect against newly emerging pandemic" exact="influenza" post="viruses because of significant antigenic differences. Potentially pandemic viruses"/>
  <result pre="would provide long-term protection not only against drifted variants of" exact="influenza" post="A viruses of one subtype but also against viruses"/>
  <result pre="approach to expanding the spectrum of the protective action of" exact="influenza" post="vaccines is to enhance the induction of cross-reacting immune"/>
  <result pre="cross-reacting immune response factors that target highly conserved antigens in" exact="influenza" post="viruses of various subtypes [61, 62]. The influenza virion"/>
  <result pre="antigens in influenza viruses of various subtypes [61, 62]. The" exact="influenza" post="virion contains multiple conservative domains that, because of their"/>
  <result pre="the hemagglutinin which is important for the penetration of the" exact="influenza" post="virus into the cell [63]; broadly immunogenic epitopes located"/>
  <result pre="cells specific to conserved viral epitopes with cross-protection against symptomatic" exact="influenza" post="in the absence of cross-reactive neutralizing antibodies [111]. Historical"/>
  <result pre="of studying M2 protein Most attempts to create a universal" exact="influenza" post="vaccine have been based on the M2e epitopes. The"/>
  <result pre="in 1981 [65]. Several groups had already shown that the" exact="influenza" post="A virus has a segmented genome consisting of 8"/>
  <result pre="new protein with greater electrophoretic mobility than the already known" exact="influenza" post="A protein. Isolation of different mRNA segments followed by"/>
  <result pre="concluded that the 7th segment of the mRNA of the" exact="influenza" post="A genome and the new M2 protein were genetically"/>
  <result pre="detected only in infected cells [65], and not in the" exact="influenza" post="virions themselves, which made it possible to put forward"/>
  <result pre="is not able to inhibit the adsorption and penetration of" exact="influenza" post="virus into cells, but is able to limit the"/>
  <result pre="into cells, but is able to limit the growth of" exact="influenza" post="A virus in vitro, though this restriction is highly"/>
  <result pre="monoclonal antibody (3F12), which not only had cross-reactivity to different" exact="influenza" post="A strains, but could also bind to the T-cell"/>
  <result pre="a bispecific antibody is able to limit the growth of" exact="influenza" post="A virus in vitro (with less efficiency than 14C2)"/>
  <result pre="N-terminus of M2 (a.a 2–12) have virus-neutralizing activity against both" exact="influenza" post="A and B in vitro [77]. The authors suggested"/>
  <result pre="additional evidence that could confirm that anti-M2e immunity can suppress" exact="influenza" post="B virus replication. Later, the same group of scientists"/>
  <result pre="the M2e2–6 epitope [37] and may provide immediate immunity against" exact="influenza" post="A infection [99]. Another potential therapeutic antibody is anti-M2e"/>
  <result pre="which play an important role in the life cycle of" exact="influenza" post="virus [115]. Highly conserved and oxidized cysteine residues at"/>
  <result pre="acid residues and is a highly conserved region in all" exact="influenza" post="A viruses. One of the reasons for the low"/>
  <result pre="27,253 human, 15,367 avian and 5379 swine individual sequences of" exact="influenza" post="A virus M gene (obtained from the Influenza Research"/>
  <result pre="[76]. As shown on Fig. 1a, the M2e sequences of" exact="influenza" post="A viruses have evolutionary diverged into several lineages mainly"/>
  <result pre="exception is the residue at 19th position in the swine" exact="influenza" post="viruses that fall into lineage 2, in which Tyr"/>
  <result pre="not protect the animals from the lethal swine subtype of" exact="influenza" post="A virus [41]. It has also been shown that"/>
  <result pre="substitution at the 11th position in avian M2e may allow" exact="avian influenza" post="A virus to escape the immune response in humans"/>
  <result pre="at the 11th position in avian M2e may allow avian" exact="influenza" post="A virus to escape the immune response in humans"/>
  <result pre="available M2e sequences, in order to develop a M2e-based universal" exact="influenza" post="vaccine we propose using four different consensus M2e protein"/>
  <result pre="protein sequences that will cover most human, avian and swine" exact="influenza" post="A viruses (Fig. 1c). In contrast to previously published"/>
  <result pre="studies, we suggest using two different M2e sequences for human" exact="influenza" post="viruses due to the significant variations between the human"/>
  <result pre="Fig. 1 Analysis of M2e sequences of human, swine and" exact="avian influenza" post="viruses. a Phylogenetic tree was generated from 27,253 human,"/>
  <result pre="1 Analysis of M2e sequences of human, swine and avian" exact="influenza" post="viruses. a Phylogenetic tree was generated from 27,253 human,"/>
  <result pre="27,253 human, 15,367 avian and 5379 swine individual sequences of" exact="influenza" post="A virus M gene (obtained from the Influenza Research"/>
  <result pre="Proposed consensus M2e sequences for the development of a universal" exact="influenza" post="vaccine The structure of free M2e is currently unknown."/>
  <result pre="aliphatic helix (a.a. 51–59) [104]. The 7th segment of the" exact="influenza" post="A virus genome can be subjected to alternative splicing"/>
  <result pre="some strains [100]. This process can proceed independently of other" exact="influenza" post="A virus proteins [68] using only the host cell"/>
  <result pre="have reported the control of M1 mRNA splicing using other" exact="influenza" post="A virus proteins [10, 100, 106, 107]. Currently, it"/>
  <result pre="four fragments of H37xxxW41 [4, 118, 125]. Shortly after the" exact="influenza" post="virus enters a cell as part of the endosome"/>
  <result pre="M2 is participation in the formation and budding of new" exact="influenza" post="A virions. The study of this feature began with"/>
  <result pre="despite the small amount of M2 on the surface of" exact="influenza" post="A virus [83]. Using reverse genetics and mutational analysis,"/>
  <result pre="the cell membrane (reviewed in [81]). Furthermore, the M2 of" exact="influenza" post="A virus is a mediator of macroautophagy inhibition at"/>
  <result pre="a subsequent increase in cell death as a result of" exact="influenza" post="infection and an increase in viral antigen yield [7,"/>
  <result pre="in viral antigen yield [7, 34]. The functional ortholog of" exact="influenza" post="A virus M2 is M2 from influenza B virus"/>
  <result pre="functional ortholog of influenza A virus M2 is M2 from" exact="influenza" post="B virus (BM2), which also carries electrons through the"/>
  <result pre="also carries electrons through the membrane [86], interacts with the" exact="influenza" post="B matrix 1 protein [127], crucial for virus assembly"/>
  <result pre="which is obtained by splicing the 7th segment of the" exact="influenza" post="A virus genome in some influenza strains [136]. Despite"/>
  <result pre="7th segment of the influenza A virus genome in some" exact="influenza" post="strains [136]. Despite the importance of the M2 functions,"/>
  <result pre="the M2 functions, it is not an essential protein for" exact="influenza" post="A virus. In laboratory practice, so-called &quot;M2 null�? viruses"/>
  <result pre="been generated and evaluated as a possible candidate for live" exact="influenza" post="vaccine. The M2SR vaccine was able to infect cells"/>
  <result pre="proved efficient in protecting animals (mice and ferrets) against heterologous/heterosubtypic" exact="influenza" post="virus infections [39, 40], and is now undergoing phase"/>
  <result pre="[19, 22, 59]. Importantly, several groups have noted that M2e-based" exact="influenza" post="vaccines induced a long-lasting M2e-specific antibody response [56, 105,"/>
  <result pre="of new viral particles. However, it has been shown that" exact="influenza" post="viruses that have mutations in the C-terminal region of"/>
  <result pre="Van den Hoecke et al. [124] showed that protection against" exact="influenza" post="virus with different IgG antibody subclasses requires different FcR"/>
  <result pre="also raises questions [71]. The complement system can bind to" exact="influenza" post="virions in the presence of virus-specific antibodies [8, 43]."/>
  <result pre="by mucosal CTA1-3M2e-DD vaccine in protecting mice against a lethal" exact="influenza" post="virus infection. Importantly, these CD4 T-cell responses were long-lasting,"/>
  <result pre="of M2e Most studies aimed at preparing a universal M2e-based" exact="influenza" post="vaccine have used the whole M2 ectodomain (a.a. 2–24)."/>
  <result pre="these antibodies have different protective characteristics, and an optimum universal" exact="influenza" post="vaccine may use only some of the M2e sites"/>
  <result pre="the M2e 7–13 site) did not protect mice against lethal" exact="influenza" post="A virus challenge. Data from other groups indicate that"/>
  <result pre="Development of M2e-based vaccines The inhibition of replication of some" exact="influenza" post="A strains by 14C2 antibody [140] merited further study"/>
  <result pre="BALB/c mice showed that it significantly reduced the replication of" exact="influenza" post="A (but not influenza B) virus in lung tissue."/>
  <result pre="it significantly reduced the replication of influenza A (but not" exact="influenza" post="B) virus in lung tissue. This prompted the suggestion"/>
  <result pre="that the higher immunity of adults who have previously had" exact="influenza" post="A infection compared with children is provided by the"/>
  <result pre="immunogen and that only about half the people infected with" exact="influenza" post="A virus are able to produce anti-M2e antibodies [143]."/>
  <result pre="been suggested that the introduction of M2e epitopes into the" exact="influenza" post="vaccine will have a priming effect on the production"/>
  <result pre="a priming effect on the production of antibodies before subsequent" exact="influenza" post="A virus infection [143]. Despite numerous reports of the"/>
  <result pre="and the possible shielding effect of larger surface proteins of" exact="influenza" post="A virus [29, 47, 140], it has been shown"/>
  <result pre="high titers of anti-M2e antibodies that protect mice from lethal" exact="influenza" post="challenge [138]. However, most attempts to create a universal"/>
  <result pre="challenge [138]. However, most attempts to create a universal M2e-based" exact="influenza" post="vaccine have used different carriers. One of the first"/>
  <result pre="the first studies used a recombinant baculovirus containing M2 from" exact="influenza" post="virus A/Ann Arbor/6/60 (Bac-AM2), to infect the Spodoptera frugipedra"/>
  <result pre="the antibody response to M2 in people previously infected with" exact="influenza" post="A virus [11]. One of the first prototypes of"/>
  <result pre="virus [11]. One of the first prototypes of a universal" exact="influenza" post="vaccine used hepatitis B core protein combined with the"/>
  <result pre="of the first prototypes of a universal influenza vaccine used" exact="hepatitis" post="B core protein combined with the M2e peptide (M2HBc)"/>
  <result pre="a high level of protection against the lethal dose of" exact="influenza" post="A virus, and led to the formation of anti-M2e"/>
  <result pre="which protected vaccinated mice from a lethal dose of mouse-adapted" exact="influenza" post="virus [17]. The most effective and cost-effective method is"/>
  <result pre="repeats (M2e5x). The intramuscular administration of M2e5x protected mice from" exact="influenza" post="A viruses of different serotypes [56, 58, 74]. There"/>
  <result pre="are also being sought, such as priming with live attenuated" exact="influenza" post="virus, and boosting with M2e VLP [73]. Table 2"/>
  <result pre="n/m, not mentioned; +, with adjuvant Clinical studies of M2e-based" exact="influenza" post="vaccines M2e-based vaccines are not available commercially, but some"/>
  <result pre="time [clinicaltrials.gov NCT00819013]. A similar recombinant protein HBc-based prototype universal" exact="influenza" post="vaccine, &quot;Uniflu�?, is currently being evaluated in a single-site,"/>
  <result pre="VA Pharma LLC (Russian Federation) I 2018 NCT03789539 No Another" exact="influenza" post="vaccine based on the use of flagellin to increase"/>
  <result pre="as parenteral administration provided immediate immunity and therapeutic benefit in" exact="influenza" post="A infection [99]. Overall, many prototype universal influenza vaccines"/>
  <result pre="benefit in influenza A infection [99]. Overall, many prototype universal" exact="influenza" post="vaccines contain an increased number of M2e epitopes. The"/>
  <result pre="spread of influenza. However, seasonal vaccination is ineffective against pandemic" exact="influenza" post="viruses, as it is often antigenically different from the"/>
  <result pre="new vaccine candidate for deployment. The development of a universal" exact="influenza" post="vaccine, which would have a long and broad spectrum"/>
  <result pre="an urgent issue of practical public health. Currently, new universal" exact="influenza" post="vaccines are being developed using various strategies, but none"/>
  <result pre="been licensed so far. The development of a new universal" exact="influenza" post="vaccine will both avoid the need for annual updates"/>
  <result pre="long-lasting protection. It is also unknown how the effects of" exact="influenza" post="viruses and previous vaccinations will affect the performance of"/>
  <result pre="affect the performance of new vaccines [91]. Ideally, a universal" exact="influenza" post="vaccine should induce both a humoral (antibodies) and a"/>
  <result pre="and a T-cell immune response to conservative epitopes of the" exact="influenza" post="virus. M2e and HA stalk domain are the most"/>
  <result pre="are the most widely used viral targets for a universal" exact="influenza" post="vaccine design due to their conserved nature and the"/>
  <result pre="between the two HA groups, suggesting that a cHA-based universal" exact="influenza" post="vaccine has to include three components: a group 1"/>
  <result pre="a group 1 HA, a group 2 HA, and an" exact="influenza" post="B stalk-based antigen [64, 82]. In contrast, a properly"/>
  <result pre="In contrast, a properly designed M2e-based vaccine should cover all" exact="influenza" post="A virus subtypes circulating in both human and animal"/>
  <result pre="to maximize cross-reactivity of the M2e-targeted antibody against all circulating" exact="influenza" post="A viruses (Fig. 1). Licensing of a new M2e-based"/>
  <result pre="neutralizing immunity, therefore the problem of proving non-inferiority over existing" exact="influenza" post="vaccines remains to be solved. Nevertheless, the conserved M2"/>
  <result pre="strain specificity and improve long-term cross-protection of currently licensed seasonal" exact="influenza" post="vaccines [57, 87]. It is worth mentioning that it"/>
  <result pre="affecting the conserved M2e region also require changes in other" exact="influenza" post="A viral proteins because of the various functions of"/>
  <result pre="acid ADCC Antibody-dependent cellular cytotoxicity Bac-AM2 Baculovirus containing M2 from" exact="influenza" post="virus A/Ann Arbor/6/60 BLS Brucella abortus lumazine synthase protein"/>
  <result pre="in VesiVax((R)) liposomes stimulates protection against type a strains of" exact="influenza" post="comparable to liposomes with multimeric forms of M2eJ Liposome"/>
  <result pre="Res201727321022010.1080/08982104.2017.138170828922045 2.AlvarezPZylbermanVGhersiGBoadoLPalaciosCGoldbaumFMattionNTandem repeats of the extracellular domain of matrix 2" exact="influenza" post="protein exposed in Brucella lumazine synthase decameric carrier molecule"/>
  <result pre="induce protection in miceVaccine201331580681210.1016/j.vaccine.2012.11.07223246552 3.AnderssonAMHakanssonKOJensenBAChristensenDAndersenPThomsenARChristensenJPIncreased immunogenicity and protective efficacy of" exact="influenza" post="M2e fused to a tetramerizing proteinPLoS One2012710111 4.BalannikVCarnevaleVFiorinGLevineBGLambRAKleinMLDegradoWFPintoLHFunctional studies"/>
  <result pre="4.BalannikVCarnevaleVFiorinGLevineBGLambRAKleinMLDegradoWFPintoLHFunctional studies and modeling of pore-lining residue mutants of the" exact="influenza" post="a virus M2 ion channelBiochemistry201049469670810.1021/bi901799k20028125 5.BangaruSLangSSchotsaertMVandervenHAZhuXKoseNBombardiRFinnJAKentSJGilchukPGilchukITurnerHLGarcia-SastreALiSWardABWilsonIACroweJEJrA Site of Vulnerability"/>
  <result pre="response in lung tissueJ Virol1996707441144188676464 7.BealeRWiseHStuartARavenhillBJDigardPRandowFA LC3-interacting motif in the" exact="influenza" post="a virus M2 protein is required to subvert autophagy"/>
  <result pre="Normal human sera: mechanisms involving antibody and complementJ Immunol19831303131713226822737 9.BerlandaSFTsvetnitskyVDonnellyJJUniversal" exact="influenza" post="vaccines: shifting to better vaccinesVaccine201634262926293310.1016/j.vaccine.2016.03.08527038130 10.BierKYorkAFodorECellular cap-binding proteins associate"/>
  <result pre="vaccines: shifting to better vaccinesVaccine201634262926293310.1016/j.vaccine.2016.03.08527038130 10.BierKYorkAFodorECellular cap-binding proteins associate with" exact="influenza" post="virus mRNAsJ Gen Virol201192Pt 71627163410.1099/vir.0.029231-021402597 11.BlackRARotaPAGorodkovaNKlenkHDKendalAPAntibody response to the"/>
  <result pre="Gen Virol201192Pt 71627163410.1099/vir.0.029231-021402597 11.BlackRARotaPAGorodkovaNKlenkHDKendalAPAntibody response to the M2 protein of" exact="influenza" post="a virus expressed in insect cellsJ Gen Virol19937414314610.1099/0022-1317-74-1-1438423445 12.ChenBJLeserGPJacksonDLambRAThe"/>
  <result pre="influenza a virus expressed in insect cellsJ Gen Virol19937414314610.1099/0022-1317-74-1-1438423445 12.ChenBJLeserGPJacksonDLambRAThe" exact="influenza" post="virus M2 protein cytoplasmic tail interacts with the M1"/>
  <result pre="at the site of virus buddingJ Virol20088220100591007010.1128/JVI.01184-0818701586 13.CheungTKGuanYNgSSChenHWongCHPeirisJSPoonLLGeneration of recombinant" exact="influenza" post="a virus without M2 ion-channel protein by introduction of"/>
  <result pre="Virol200586Pt 51447145410.1099/vir.0.80727-015831957 14.ChizhmakovIVGeraghtyFMOgdenDCHayhurstAAntoniouMHayAJSelective proton permeability and pH regulation of the" exact="influenza" post="virus M2 channel expressed in mouse erythroleukaemia cellsJ Physiol1996494232933610.1113/jphysiol.1996.sp0214958841994"/>
  <result pre="HammeESchymkowitzJRousseauFFiersWSaelensXKimKHStructure of the extracellular domain of matrix protein 2 of" exact="influenza" post="a virus in complex with a protective monoclonal antibodyJ"/>
  <result pre="FiletteMYsenbaertTRooseKSchotsaertMRoelsSGoossensESchepensBFiersWSaelensXAntiserum against the conserved nine amino acid N-terminal peptide of" exact="influenza" post="a virus matrix protein 2 is not immunoprotectiveJ Gen"/>
  <result pre="RooijenNVerbeekSFiersWSaelensXUniversal vaccine based on ectodomain of matrix protein 2 of" exact="influenza" post="a: fc receptors and alveolar macrophages mediate protectionJ Immunol201118621022103110.4049/jimmunol.090214721169548"/>
  <result pre="mediate protectionJ Immunol201118621022103110.4049/jimmunol.090214721169548 25.EliassonDGEl BakkouriKSchonKRamneAFestjensELowenadlerBFiersWSaelensXLyckeNCTA1-M2e-DD: a novel mucosal adjuvant targeted" exact="influenza" post="vaccineVaccine20082691243125210.1016/j.vaccine.2007.12.02718243429 26.EliassonDGOmokanyeASchonKWenzelUABernasconiVBemarkMKolpeAEl BakkouriKYsenbaertTDengLFiersWSaelensXLyckeNM2e-tetramer-specific memory CD4 T cells are broadly"/>
  <result pre="26.EliassonDGOmokanyeASchonKWenzelUABernasconiVBemarkMKolpeAEl BakkouriKYsenbaertTDengLFiersWSaelensXLyckeNM2e-tetramer-specific memory CD4 T cells are broadly protective against" exact="influenza" post="infectionMucosal Immunol201811127328910.1038/mi.2017.1428295019 27.EpsteinSLUniversal Influenza vaccines: Progress in achieving broad"/>
  <result pre="achieving broad cross-protection in vivoAm J Epidemiol2018187122603261430084906 28.FanJLiangXHortonMSPerryHCCitronMPHeideckerGJFuTMJoyceJPrzysieckiCTKellerPMGarskyVMIonescuRRippeonYShiLChastainMACondraJHDaviesMELiaoJEminiEAShiverJWPreclinical study of" exact="influenza" post="virus a M2 peptide conjugate vaccines in mice, ferrets,"/>
  <result pre="inhibit virus replication in vitroJ Virol1996707480048048676511 31.FiersWDe FiletteMEl BakkouriKSchepensBRooseKSchotsaertMBirkettASaelensXM2e-based universal" exact="influenza" post="a vaccineVaccine200927456280628310.1016/j.vaccine.2009.07.00719840661 32.FuT-MFreedDCHortonMSFanJCitronMPJoyceJGGarskyVMCasimiroDRZhaoQShiverJWLiangXCharacterizations of four monoclonal antibodies against M2"/>
  <result pre="32.FuT-MFreedDCHortonMSFanJCitronMPJoyceJGGarskyVMCasimiroDRZhaoQShiverJWLiangXCharacterizations of four monoclonal antibodies against M2 protein ectodomain of" exact="influenza" post="a virusVirology2009385121822610.1016/j.virol.2008.11.03519070878 33.FuruseYSuzukiAKamigakiTOshitaniHEvolution of the M gene of the"/>
  <result pre="influenza a virusVirology2009385121822610.1016/j.virol.2008.11.03519070878 33.FuruseYSuzukiAKamigakiTOshitaniHEvolution of the M gene of the" exact="influenza" post="a virus in different host species: large-scale sequence analysisVirol"/>
  <result pre="host species: large-scale sequence analysisVirol J200966710.1186/1743-422X-6-6719476650 34.GannageMDormannDAlbrechtRDengjelJTorossiTRamerPCLeeMStrowigTArreyFConenelloGPypaertMAndersenJGarcia-SastreAMunzCMatrix protein 2 of" exact="influenza" post="a virus blocks autophagosome fusion with lysosomesCell Host Microbe20096436738010.1016/j.chom.2009.09.00519837376"/>
  <result pre="virus blocks autophagosome fusion with lysosomesCell Host Microbe20096436738010.1016/j.chom.2009.09.00519837376 35.GeorgievaERBorbatPPNormanHDFreedJHMechanism of" exact="influenza" post="a M2 transmembrane domain assembly in lipid membranesSci Rep201551175710.1038/srep1175726190831"/>
  <result pre="protective epitope that is highly conserved among human and nonhuman" exact="influenza" post="A virusesProc Natl Acad Sci U S A20101072812665811266310.1073/pnas.0911806107 38.HashemiHPouyanfardSBandehpourMNoroozbabaeiZKazemiBSaelensXMokhtari-AzadTImmunization"/>
  <result pre="S A20101072812665811266310.1073/pnas.0911806107 38.HashemiHPouyanfardSBandehpourMNoroozbabaeiZKazemiBSaelensXMokhtari-AzadTImmunization with M2e-displaying T7 bacteriophage nanoparticles protects against" exact="influenza" post="a virus challengePLoS One201279e4576510.1371/journal.pone.004576523029232 39.HattaYBoltzDSarawarSKawaokaYNeumannGBilselPM2SR, a novel live influenza"/>
  <result pre="against influenza a virus challengePLoS One201279e4576510.1371/journal.pone.004576523029232 39.HattaYBoltzDSarawarSKawaokaYNeumannGBilselPM2SR, a novel live" exact="influenza" post="vaccine, protects mice and ferrets against highly pathogenic avian"/>
  <result pre="protects mice and ferrets against highly pathogenic avian influenzaVaccine201735334177418310.1016/j.vaccine.2017.06.03928668565 40.HattaYBoltzDSarawarSKawaokaYNeumannGBilselPNovel" exact="influenza" post="vaccine M2SR protects against drifted H1N1 and H3N2 influenza"/>
  <result pre="40.HattaYBoltzDSarawarSKawaokaYNeumannGBilselPNovel influenza vaccine M2SR protects against drifted H1N1 and H3N2" exact="influenza" post="virus challenge in ferrets with pre-existing immunityVaccine201836335097510310.1016/j.vaccine.2018.06.05330007825 41.HeinenPPRijsewijkFAde Boer-LuijtzevEABianchiATVaccination"/>
  <result pre="41.HeinenPPRijsewijkFAde Boer-LuijtzevEABianchiATVaccination of pigs with a DNA construct expressing an" exact="influenza" post="virus M2–nucleoprotein fusion protein exacerbates disease after challenge with"/>
  <result pre="influenza virus M2–nucleoprotein fusion protein exacerbates disease after challenge with" exact="influenza" post="a virusJ Gen Virol2002831851185910.1099/0022-1317-83-8-185112124449 42.HeleniusAUnpacking the incoming Influenza virusCell19926957757810.1016/0092-8674(92)90219-31375129"/>
  <result pre="by formation of disulfide bondsVirology19911831324310.1016/0042-6822(91)90115-R2053285 45.HugheyPGRobertsPCHolsingerLJZebedeeSLLambRACompansRWEffects of antibody to the" exact="influenza" post="a virus M2 protein on M2 surface expression and"/>
  <result pre="and virus assemblyVirology1995212241142110.1006/viro.1995.14987571410 46.HuleattJWNakaarVDesaiPHuangYHewittDJacobsATangJMcDonaldWSongLEvansRKUmlaufSTusseyLPowellTJPotent immunogenicity and efficacy of a universal" exact="influenza" post="vaccine candidate comprising a recombinant fusion protein linking influenza"/>
  <result pre="universal influenza vaccine candidate comprising a recombinant fusion protein linking" exact="influenza" post="M2e to the TLR5 ligand flagellinVaccine200826220121410.1016/j.vaccine.2007.10.06218063235 47.HutchinsonECCharlesPDHesterSSThomasBTrudgianDMartinez-AlonsoMFodorEConserved and host-specific"/>
  <result pre="to the TLR5 ligand flagellinVaccine200826220121410.1016/j.vaccine.2007.10.06218063235 47.HutchinsonECCharlesPDHesterSSThomasBTrudgianDMartinez-AlonsoMFodorEConserved and host-specific features of" exact="influenza" post="virion architectureNat Commun20145481610.1038/ncomms581625226414 48.HutchinsonECCurranMDReadEKGogJRDigardPMutational analysis of cis-acting RNA signals"/>
  <result pre="48.HutchinsonECCurranMDReadEKGogJRDigardPMutational analysis of cis-acting RNA signals in segment 7 of" exact="influenza" post="a virusJ Virol20088223118691187910.1128/JVI.01634-0818815307 49.IchinoheTPangIKIwasakiAInfluenza virus activates inflammasomes via its"/>
  <result pre="into virions during virus assemblyJ Virol20047820110071101510.1128/JVI.78.20.11007-11015.200415452221 51.ItoTGormanOTKawaokaYBeanWJWebsterRJEvolutionary analysis of the" exact="influenza" post="a virus M gene with comparison of the M1"/>
  <result pre="virus-like particles confer broader and stronger M2 immunity than live" exact="influenza" post="A virus infectionAntiviral Res201399332833510.1016/j.antiviral.2013.06.01023811283 57.KimMCLeeYNKoEJLeeJSKwonYMHwangHSSongJMSongBMLeeYJChoiJGKangHMQuanFSCompansRWKangSMSupplementation of influenza split vaccines"/>
  <result pre="immunity than live influenza A virus infectionAntiviral Res201399332833510.1016/j.antiviral.2013.06.01023811283 57.KimMCLeeYNKoEJLeeJSKwonYMHwangHSSongJMSongBMLeeYJChoiJGKangHMQuanFSCompansRWKangSMSupplementation of" exact="influenza" post="split vaccines with conserved M2 ectodomains overcomes strain specificity"/>
  <result pre="M2 extracellular domains confer improved cross-protection against various subtypes of" exact="influenza" post="virusMol Ther201321248549210.1038/mt.2012.24623247101 59.KolpeASchepensBFiersWSaelensXM2-based influenza vaccines: recent advances and clinical"/>
  <result pre="improved cross-protection against various subtypes of influenza virusMol Ther201321248549210.1038/mt.2012.24623247101 59.KolpeASchepensBFiersWSaelensXM2-based" exact="influenza" post="vaccines: recent advances and clinical potentialExpert Rev Vaccines201716212313610.1080/14760584.2017.124004127653543 60.KolpeASchepensBYeLStaeheliPSaelensXPassively"/>
  <result pre="clinical potentialExpert Rev Vaccines201716212313610.1080/14760584.2017.124004127653543 60.KolpeASchepensBYeLStaeheliPSaelensXPassively transferred M2e-specific monoclonal antibody reduces" exact="influenza" post="a virus transmission in miceAntivir Res201815824425410.1016/j.antiviral.2018.08.01730179634 61.KrammerFEmerging influenza viruses"/>
  <result pre="antibody reduces influenza a virus transmission in miceAntivir Res201815824425410.1016/j.antiviral.2018.08.01730179634 61.KrammerFEmerging" exact="influenza" post="viruses and the prospect of a universal influenza virus"/>
  <result pre="Res201815824425410.1016/j.antiviral.2018.08.01730179634 61.KrammerFEmerging influenza viruses and the prospect of a universal" exact="influenza" post="virus vaccineBiotechnol J201510569070110.1002/biot.20140039325728134 62.KrammerFPalesePAdvances in the development of influenza"/>
  <result pre="universal influenza virus vaccineBiotechnol J201510569070110.1002/biot.20140039325728134 62.KrammerFPalesePAdvances in the development of" exact="influenza" post="virus vaccinesNat Rev Drug Discov201514316718210.1038/nrd452925722244 63.KrammerFPalesePInfluenza virus hemagglutinin stalk-based"/>
  <result pre="virus hemagglutinin stalk-based antibodies and vaccinesCurr Opin Virol20133552153010.1016/j.coviro.2013.07.00723978327 64.KrammerFPicaNHaiRMargineIPalesePChimeric hemagglutinin" exact="influenza" post="virus vaccine constructs elicit broadly protective stalk-specific antibodiesJ Virol201387126542655010.1128/JVI.00641-1323576508"/>
  <result pre="RNA segment 7 of Influenza virusVirology198111272973710.1016/0042-6822(81)90317-27257188 66.LambRAChoppinPWSegment 8 of the" exact="influenza" post="virus genome is unique in coding for two polypeptidesBiochemistry1979761049084912"/>
  <result pre="antibodies but plays a critical role in conferring protection after" exact="influenza" post="M2 vaccinationImmunology2014143230030910.1111/imm.1231024773389 73.LeeYTKimKHKoEJKimMCLeeYNHwangHSLeeYJungYJKimYJSantosJPerezDRKangSMEnhancing the cross protective efficacy of live"/>
  <result pre="M2 vaccinationImmunology2014143230030910.1111/imm.1231024773389 73.LeeYTKimKHKoEJKimMCLeeYNHwangHSLeeYJungYJKimYJSantosJPerezDRKangSMEnhancing the cross protective efficacy of live attenuated" exact="influenza" post="virus vaccine by supplemented vaccination with M2 ectodomain virus-like"/>
  <result pre="induces humoral and cellular immune responses conferring cross-protection against heterosubtypic" exact="influenza" post="virusesPLoS One2018131e019086810.1371/journal.pone.019086829324805 75.LeidingTWangJMartinssonJDeGradoWFArskoldSPProton and cation transport activity of the"/>
  <result pre="and cation transport activity of the M2 proton channel from" exact="influenza" post="a virusProc Natl Acad Sci U S A201010735154091541410.1073/pnas.100999710720713739 76.LetunicIBorkPInteractive"/>
  <result pre="of M2 protein could induce antibodies with inhibitory activity against" exact="influenza" post="virus replicationFEMS Immunol Med Microbiol200335214114610.1016/S0928-8244(03)00009-912628550 78.LiuWZouPChenYHMonoclonal antibodies recognizing EVETPIRN"/>
  <result pre="replicationFEMS Immunol Med Microbiol200335214114610.1016/S0928-8244(03)00009-912628550 78.LiuWZouPChenYHMonoclonal antibodies recognizing EVETPIRN epitope of" exact="influenza" post="a virus M2 protein could protect mice from lethal"/>
  <result pre="influenza a virus M2 protein could protect mice from lethal" exact="influenza" post="a virus challengeImmunol Lett2004932–313113610.1016/j.imlet.2004.03.00315158608 79.LiuWZouPDingJLuYChenYHSequence comparison between the extracellular"/>
  <result pre="comparison between the extracellular domain of M2 protein human and" exact="avian influenza" post="a virus provides new information for bivalent influenza vaccine"/>
  <result pre="between the extracellular domain of M2 protein human and avian" exact="influenza" post="a virus provides new information for bivalent influenza vaccine"/>
  <result pre="and avian influenza a virus provides new information for bivalent" exact="influenza" post="vaccine designMicrobes Infect20057217117710.1016/j.micinf.2004.10.00615777646 80.LotfiZGolchinMKhalili-YazdiAKhaliliMImmunological properties of the SLLTEVET epitope"/>
  <result pre="Sciences20171812264910.3390/ijms18122649 82.MargineIKrammerFHaiRHeatonNSTanGSAndrewsSARunstadlerJAWilsonPCAlbrechtRAGarcia-SastreAPalesePHemagglutinin stalk-based universal vaccine constructs protect against group 2" exact="influenza" post="a virusesJ Virol20138719104351044610.1128/JVI.01715-1323903831 83.McCownMFPekoszAThe influenza a virus M2 cytoplasmic"/>
  <result pre="constructs protect against group 2 influenza a virusesJ Virol20138719104351044610.1128/JVI.01715-1323903831 83.McCownMFPekoszAThe" exact="influenza" post="a virus M2 cytoplasmic tail is required for infectious"/>
  <result pre="M2e5x virus-like particles confers improved cross-protection in ferretsVaccine201634446647310.1016/j.vaccine.2015.12.02326709639 88.NeirynckSDerooTSaelensXVanlandschootPJouWMFiersWA universal" exact="influenza" post="a vaccine based on the extracellular domain of the"/>
  <result pre="extracellular domain of the M2 proteinNat Med19995101157116310.1038/1348410502819 89.OkudaKIhataAWatabeSOkadaEYamakawaTHamajimaKYangJIshiiNNakazawaMOkudaKOhnariKNakajimaKXinKQProtective immunity against" exact="influenza" post="a virus induced by immunization with DNA plasmid containing"/>
  <result pre="influenza a virus induced by immunization with DNA plasmid containing" exact="influenza" post="M geneVaccine2001193681369110.1016/S0264-410X(01)00078-011395202 90.PalesePSchulmanJLDifferences in RNA patterns of Influenza a"/>
  <result pre="the possible dream?ACS Infect Dis2016215710.1021/acsinfecdis.5b0014626977452 92.ParkKSSeoYBLeeJYImSJSeoSHSongMSChoiYKSungYCComplete protection against a H5N2" exact="avian influenza" post="virus by a DNA vaccine expressing a fusion protein"/>
  <result pre="possible dream?ACS Infect Dis2016215710.1021/acsinfecdis.5b0014626977452 92.ParkKSSeoYBLeeJYImSJSeoSHSongMSChoiYKSungYCComplete protection against a H5N2 avian" exact="influenza" post="virus by a DNA vaccine expressing a fusion protein"/>
  <result pre="94.PejoskiDZengWRockmanSBrownLEJacksonDCA lipopeptide based on the M2 and HA proteins of" exact="influenza" post="a viruses induces protective antibodyImmunol Cell Biol201088560561110.1038/icb.2010.1520177411 95.PetrieJGMaloshREChengCKOhmitSEMartinETJohnsonETrusconREichelbergerMCGubarevaLVFryAMMontoASThe household"/>
  <result pre="virus M2 protein has ion channel activityCell19926951752810.1016/0092-8674(92)90452-I1374685 98.PonsMWA reexamination of" exact="influenza" post="single- and double-stranded RNAs by gel electrophoresisVirology19766978979210.1016/0042-6822(76)90508-01258370 99.RamosELMitchamJLKollerTDBonaviaAUsnerDWBalaratnamGFredlundPSwiderekKMEfficacy and"/>
  <result pre="antibody in experimental human influenzaJ Infect Dis201521171038104410.1093/infdis/jiu53925281755 100.RobbNCFodorEThe accumulation of" exact="influenza" post="a virus segment 7 spliced mRNAs is regulated by"/>
  <result pre="Journal of Infectious Diseases2019219Supplement_1S68S7410.1093/infdis/jiz00330715367 103.SarawarSHattaYWatanabeSDiasPNeumannGKawaokaYBilselPM2SR, a novel live single replication" exact="influenza" post="virus vaccine, provides effective heterosubtypic protection in miceVaccine201634425090509810.1016/j.vaccine.2016.08.06127595896 104.SchnellJRChouJJStructure"/>
  <result pre="miceVaccine201634425090509810.1016/j.vaccine.2016.08.06127595896 104.SchnellJRChouJJStructure and mechanism of the M2 proton channel of" exact="influenza" post="a virusNature2008451717859159510.1038/nature0653118235503 105.SchotsaertMYsenbaertTSmetASchepensBVanderschaegheDStegalkinaSVogelTUCallewaertNFiersWSaelensXLong-lasting cross-protection against Influenza a by neuraminidase"/>
  <result pre="polymerase proteinsVirology199622643043510.1006/viro.1996.06738955065 107.ShihSRNemeroffMEKrugRMThe choice of alternative 5′ splice sites in" exact="influenza" post="virus M1 mRNA is regulated by the viral polymerase"/>
  <result pre="One2015104e012467710.1371/journal.pone.012467725915748 109.SmithGJVijaykrishnaDBahlJLycettSJWorobeyMPybusOGMaSKCheungCLRaghwaniJBhattSPeirisJSGuanYRambautAOrigins and evolutionary genomics of the 2009 swine-origin H1N1" exact="influenza" post="a epidemicNature200945972501122112510.1038/nature0818219516283 110.SongJMWangBZParkKMRooijenNVQuanFSKimMCJinHTPekoszACompansRWKangSMInfluenza virus-like particles containing M2 induce broadly"/>
  <result pre="a high K+ concentration is required for efficient uncoating of" exact="influenza" post="a virus cores after penetrationJ Virol20148822130291304610.1128/JVI.01430-1425165113 113.StepanovaLAMardanovaESShuklinaMABlokhinaEAKotlyarovRYPotapchukMVKovalevaAAVidyaevaIGKorotkovAVEletskayaEIRavinNVTsybalovaLMFlagellin-fused protein targeting"/>
  <result pre="potent humoral and T-cell responses and protects mice against various" exact="influenza" post="viruses a subtypesJ Biomed Sci20182513310.1186/s12929-018-0433-529631629 114.StoloffGACaparros-WanderleyWSynthetic multi-epitope peptides identified"/>
  <result pre="multi-epitope peptides identified in silico induce protective immunity against multiple" exact="influenza" post="serotypesEur J Immunol20073792441244910.1002/eji.20073725417668898 115.StoufferALAcharyaRSalomDLevineASDi CostanzoLSotoCSTereshkoVNandaVStayrookSDeGradoWFStructural basis for the function"/>
  <result pre="115.StoufferALAcharyaRSalomDLevineASDi CostanzoLSotoCSTereshkoVNandaVStayrookSDeGradoWFStructural basis for the function and inhibition of an" exact="influenza" post="virus proton channelNature2008451717859659910.1038/nature0652818235504 116.TakedaMPekoszAShuckKPintoLHLambRAInfluenza a virus M2 Ion Channel"/>
  <result pre="for efficient replication in tissue cultureJ Virol20027631391139910.1128/JVI.76.3.1391-1399.200211773413 117.TalbotHKRockMTJohnsonCTusseyLKavitaUShankerAShawARTaylorDNImmunopotentiation of trivalent" exact="influenza" post="vaccine when given with VAX102, a recombinant influenza M2e"/>
  <result pre="of trivalent influenza vaccine when given with VAX102, a recombinant" exact="influenza" post="M2e vaccine fused to the TLR5 ligand flagellinPLoS One2010512e1444210.1371/journal.pone.001444221203437"/>
  <result pre="to the TLR5 ligand flagellinPLoS One2010512e1444210.1371/journal.pone.001444221203437 118.TangYZaitsevaFLambRAPintoLHThe gate of the" exact="influenza" post="virus M2 proton channel is formed by a single"/>
  <result pre="residueJ Biol Chem200227742398803988610.1074/jbc.M20658220012183461 119.TompkinsSMZhaoZSLoCYMisplonJALiuTYeZHoganRJWuZBentonKATumpeyTMEpsteinSLMatrix protein 2 vaccination and protection against" exact="influenza" post="viruses, including subtype H5N1Emerg Infect Dis200713342643510.3201/eid1303.06112517552096 120.TophamDITrippRADohertyPCCD8+ T cells"/>
  <result pre="a virus replication in miceJ Virol1990643137513772304147 122.TsybalovaLMStepanovaLAKuprianovVVBlokhinaEAPotapchukMVKorotkovAVGorshkovANKasyanenkoMARavinNVKiselevOIDevelopment of a candidate" exact="influenza" post="vaccine based on virus-like particles displaying influenza M2e peptide"/>
  <result pre="of a candidate influenza vaccine based on virus-like particles displaying" exact="influenza" post="M2e peptide into the immunodominant region of hepatitis B"/>
  <result pre="particles displaying influenza M2e peptide into the immunodominant region of" exact="hepatitis" post="B core antigen: broad protective efficacy of particles carrying"/>
  <result pre="copies of M2eVaccine201533293398340610.1016/j.vaccine.2015.04.07325976545 123.TurleyCBRuppREJohnsonCTaylorDNWolfsonJTusseyLKavitaUStanberryLShawASafety and immunogenicity of a recombinant M2e-flagellin" exact="influenza" post="vaccine (STF2.4xM2e) in healthy adultsVaccine201129325145515210.1016/j.vaccine.2011.05.04121624416 124.Van den Hoecke S,"/>
  <result pre="histidine selectivity filter mutants of the M2 ion channel of" exact="influenza" post="a virusJ Biol Chem200528022214632147210.1074/jbc.M41240620015784624 126.Von HolleTAMoodyMAInfluenza and antibody-dependent cellular"/>
  <result pre="cellular cytotoxicityFront Immunol201910145710.3389/fimmu.2019.0145731316510 127.WangJPielakRMMcClintockMAChouJJSolution structure and functional analysis of the" exact="influenza" post="B proton channelNat Struct Mol Biol200916121267127110.1038/nsmb.170719898475 128.WangRSongALevinJDennisDZhangNJYoshidaHKoriazovaLMaduraLShapiroLMatsumotoAYoshidaHMikayamaTKuboRTSarawarSCheroutreHKatoSTherapeutic potential of"/>
  <result pre="Biol200916121267127110.1038/nsmb.170719898475 128.WangRSongALevinJDennisDZhangNJYoshidaHKoriazovaLMaduraLShapiroLMatsumotoAYoshidaHMikayamaTKuboRTSarawarSCheroutreHKatoSTherapeutic potential of a fully human monoclonal antibody against" exact="influenza" post="a virus M2 proteinAntivir Res200880216817710.1016/j.antiviral.2008.06.00218598723 129.WangYChenLChengYZhouSPangYZhangJGreeneCMSongYZhangTZhaoGPotential impact of B"/>
  <result pre="proteinAntivir Res200880216817710.1016/j.antiviral.2008.06.00218598723 129.WangYChenLChengYZhouSPangYZhangJGreeneCMSongYZhangTZhaoGPotential impact of B lineage mismatch on trivalent" exact="influenza" post="vaccine effectiveness during the 2015-2016 influenza season among nursery"/>
  <result pre="lineage mismatch on trivalent influenza vaccine effectiveness during the 2015-2016" exact="influenza" post="season among nursery school children in SuzhouChina Hum Vaccin"/>
  <result pre="ion channel activityJ Virol200175125656566210.1128/JVI.75.12.5656-5662.200111356973 132.WhartonSABelsheRBSkehelJJHayAJRole of virion M2 protein in" exact="influenza" post="virus uncoating: specific reduction in the rate of membrane"/>
  <result pre="Gen Virol199475Pt 494594810.1099/0022-1317-75-4-9458151308 133.WHO. Antigenic and genetic characteristics of zoonotic" exact="influenza" post="viruses and candidate vaccine viruses developed for potential use"/>
  <result pre="Available at: http://www.who.int/entity/influenza/vaccines/virus/201802_zoonotic_vaccinevirusupdate.pdf?ua=1. 2018. 134.WHO. Tables on clinical evaluation of" exact="influenza" post="vaccines. Pandemic and potentially pandemic influenza vaccines. Available at:"/>
  <result pre="on clinical evaluation of influenza vaccines. Pandemic and potentially pandemic" exact="influenza" post="vaccines. Available at: http://www.who.int/entity/immunization/diseases/influenza/Table_clinical_evaluation_influenza_pandemic.xlsx?ua=1. 2018. 135.WinterGFieldsSCloning of influenza cDNA"/>
  <result pre="potentially pandemic influenza vaccines. Available at: http://www.who.int/entity/immunization/diseases/influenza/Table_clinical_evaluation_influenza_pandemic.xlsx?ua=1. 2018. 135.WinterGFieldsSCloning of" exact="influenza" post="cDNA into M13: the sequence of the RNA segment"/>
  <result pre="Res1980891965197410.1093/nar/8.9.19656927841 136.WiseHMHutchinsonECJaggerBWStuartADKangZHRobbNSchwartzmanLMKashJCFodorEFirthAEGogJRTaubenbergerJKDigardPIdentification of a novel splice variant form of the" exact="influenza" post="a virus M2 ion channel with an antigenically distinct"/>
  <result pre="Virol. 2018;92(22). 10.1128/JVI.01425-18. 138.WuFHuangJHYuanXYHuangWSChenYHCharacterization of immunity induced by M2e of" exact="influenza" post="virusVaccine200725528868887310.1016/j.vaccine.2007.09.05618061317 139.ZebedeeSLLambRAGrowth restriction of influenza a virus by M2"/>
  <result pre="immunity induced by M2e of influenza virusVaccine200725528868887310.1016/j.vaccine.2007.09.05618061317 139.ZebedeeSLLambRAGrowth restriction of" exact="influenza" post="a virus by M2 protein antibody is genetically linked"/>
  <result pre="to matrix protein 2 following natural infection with 2009 pandemic" exact="influenza" post="A(H1N1) virus in humansJ Infect Dis2014209798699410.1093/infdis/jit81124325965"/>
 </snippets>
</snippetsTree>
